Washington, DC (May 12, 2020) – The Biotechnology Innovation Organization (BIO) today unveiled a first-of-its-kind, interactive tracker of the new treatments and vaccines in the COVID-19 pipeline. This online resource illustrates the unprecedented campaign being undertaken by biopharmaceutical innovators to combat – and ultimately eradicate – the novel coronavirus. Continue reading
Author Archive: AZBio
Express Scripts Offers Prescription Cost Relief for Newly Uninsured Americans
- Unprecedented program convenes manufacturers and pharmacies to help millions of Americans access prescription medications at affordable and predictable prices
- Express Scripts Parachute RxSM will cap costs at $25 for a 30-day supply of generic drugs; $75 for a 30-day supply of brand-name medicines for a limited time
AdvaMed Issues MedTech Compliance Guidance For COVID-19 Response
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced availability of a newly created “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”
“This guidance seeks to help AdvaMed members and other medical technology companies develop and implement processes that both support rapid decision-making in the context of the pandemic and mitigate any related compliance risks,” said Christopher L. White, AdvaMed COVID action team leader, chief operating officer and general counsel.Continue reading
What is the Bipartisan Commission on Biodefense?
On January 20, 2019, AZBio hosted a thought leadership event at Barrett-Jackson Scottsdale featuring a panel discussion on Health Innovation with Dr. Anna Barker and Dr. George Poste. During the discussion, Dr. Poste, shared his thoughts on the need for governments and our industry to prepare for global pandemics and what the Bipartisan Commission on Biodefense had reported. Dr. Poste, an ex officio member of the commission, shared that is was not a matter of if a global pandemic would occur, but of when.
The first report of a COVID-19 case in the U.S. was January 20, 2020. Today, the world is learning more about what happens in a global pandemic than we ever wanted to know. And, we still have a lot more to learn.Continue reading
Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens
The authorization is limited to testing performed at the Rutgers Clinical Genomics Laboratory using their molecular LDT COVID-19 authorized test for saliva specimens collected using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device. FDA states “It is important to note that this is not a general authorization for at-home collection of patient samples using other collection methods, saliva collection devices, or tests, or for tests fully conducted at home.”
Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay
Sofia® 2 SARS Antigen FIA Point-of-Care test offers positive results in 15 minutesContinue reading
Q&A: Dr. Mary-Ann Etiebet, Executive Director, Merck for Mothers
With Mother’s Day just around the corner, BIO sat down with Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers, for a discussion about how Merck helping address maternal health needs in the United States and in countries impacted by COVID-19. Continue reading
Health Catalysts Group publishes The Diagnostics Year in Review
Led by diagnostics industry veteran Mara G. Aspinall, Health Catalysts Group is an Arizona based consulting and informatics firm focused on the success of life sciences companies.
The ALS Association Makes Multi-Year Commitment to ALS Clinical Trial Infrastructure
Funding will support a framework for greater efficiencies, collaboration in research, and enhanced patient experience during clinical trialsContinue reading
Treating COVID-19 Patients With Acute Heart Failure
A paper published in two medical journals last week offers guidelines for physicians treating coronavirus patients requiring advanced life-saving therapies.Continue reading